Company information:
Ariad Pharma Ltd (No: 06356675)
Status: Dissolved
Industry Class: None
Current Director: SCOTT DESSING ( DOB: Oct-1969 From: Jun-2017 )
Current Director: FABIEN DUBOIS ( DOB: Apr-1973 From: Jun-2017 )
Resigned Director: THIERRY STÉPHANE BATAILLARD ( From: Nov-2015 To: Jun-2016 )
Resigned Director: HARVEY JAMES BERGER ( From: Aug-2007 To: Oct-2015 )
Resigned Director: DAVID BERSTEIN ( From: Sep-2013 To: Apr-2015 )
Resigned Director: BRYAN BLACK ( From: Nov-2015 To: Jun-2016 )
Resigned Director: DANIEL MARCEL BOLLAG ( From: Jun-2016 To: May-2017 )
Resigned Director: TIMOTHY PIERS CLACKSON ( From: Jun-2016 To: May-2017 )
Resigned Director: THOMAS JAMES DESROSIER ( From: Apr-2015 To: Oct-2015 )
Resigned Director: JONATHAN ELLIOTT DICKINSON ( From: Nov-2015 To: Jun-2016 )
Resigned Director: EDWARD FITZGERALD ( From: Aug-2007 To: Oct-2015 )
Resigned Director: FRANK HALUSKA ( From: Jan-2009 To: Oct-2015 )
Resigned Director: DAVID RONALD JONES ( DOB: Jul-1958 From: Nov-2015 To: Jun-2016 )
Resigned Director: RAYMOND KEANE ( From: Mar-2009 To: Aug-2013 )
Resigned Director: MANMEET SINGH SONI ( From: Jun-2016 To: May-2017 )
Resigned Director: MARK EDWIN TANNER ( DOB: May-1962 From: Nov-2015 To: Jun-2016 )
Resigned Secretary: JORDAN COMPANY SECRETARIES LIMITED ( From: Aug-2007 To: Dec-2010 )
Resigned Secretary: OVALSEC LIMITED ( From: Dec-2010 To: Oct-2014 )
Resigned Secretary: SWIFT INCORPORATIONS LIMITED ( From: Aug-2007 To: Aug-2007 )
Persons of Significant Control:
Takeda Pharmaceutical Company Limited, 1-1 Doshomachi 4-Chome, Chuo-Ku, Osaka, Japan: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2017-10-25)